CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	[1]	$ 12,097	$ 8,648	$ 22,462	$ 15,401
General and administrative		4,945	2,128	9,912	3,293
Total operating expenses		17,042	10,776	32,374	18,694
Loss from operations		(17,042)	(10,776)	(32,374)	(18,694)
Other income (expense):
Change in fair value of the related party antidilution obligation			(584)		(836)
Change in fair value of Series A preferred stock tranche obligation			(7)		(28)
Interest income, net		32	1	34	3
Other income (expense), net		(5)	(1)	(9)	(3)
Total other expense, net		27	(591)	25	(864)
Net loss and comprehensive loss		$ (17,015)	$ (11,367)	$ (32,349)	$ (19,558)
Net loss per share attributable to common stockholders, basic and diluted		$ (0.60)	$ (7.48)	$ (1.18)	$ (12.96)
Weighted—average common shares outstanding, basic and diluted		28,150,051	1,518,999	27,409,264	1,509,474

[1] Includes related party amounts of $75 and $142 for the three and six months ended June 30, 2022, respectively, and $1,782 and $2,462 for the three and six months ended June 30, 2021, respectively (see Note 12).